Alpine Associates Management’s 89bio ETNB Stock Holding History

Alpine Associates Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-529,800	Closed	-$7.79M	–	75
2025 Q3	$7.79M	Buy	+529,800	New	+$5.4M	0.47%	43

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alpine Associates Management's ETNB Position: Q4 2025 in Review

Alpine Associates Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 529,800 shares — an estimated $7.79M sold.

Alpine Associates Management first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $7.79M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Alpine Associates Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Alpine Associates Management sold 529,800 89bio shares in Q4 2025, an estimated $7.79M.
Alpine Associates Management first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
Alpine Associates Management's 89bio position peaked at $7.79M in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Alpine Associates Management's 13F filing for Q4 2025, filed 5 Feb 2026.